Cargando…
Endoscopic submucosal dissection for early gastric cancer without interruption of warfarin and aspirin
Many guidelines for the management of antithrombotic therapy in endoscopic procedures state that warfarin should be replaced by heparin in high risk endoscopic procedures. However, heparin bridging therapy is costly, requires a long hospital stay, and is indicated as a risk factor for bleeding after...
Autores principales: | Tounou, Shigetaka, Morita, Yasushi, Hosono, Tomohiro, Harada, Hideaki, Hayasaka, Kenji, Katsuyama, Yasushi, Suehiro, Satoshi, Nagano, Seishi, Shimizu, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554514/ https://www.ncbi.nlm.nih.gov/pubmed/26357675 http://dx.doi.org/10.1055/s-0034-1392018 |
Ejemplares similares
-
Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study
por: Harada, Hideaki, et al.
Publicado: (2017) -
Endoscopic submucosal dissection for small submucosal tumors of the rectum compared with endoscopic submucosal resection with a ligation device
por: Harada, Hideaki, et al.
Publicado: (2017) -
Clinical impact of prophylactic clip closure of mucosal defects after colorectal endoscopic submucosal dissection
por: Harada, Hideaki, et al.
Publicado: (2017) -
Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy
por: Tounou, Shigetaka, et al.
Publicado: (2015) -
Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy
por: Harada, Hideaki, et al.
Publicado: (2019)